Zydus Lifesciences (ZYDUSLIFE) — Board Meeting

Zydus Lifesciences reported Q2 FY2025-26 standalone net profit of ₹11,566 million and consolidated net profit of ₹12,586 million, with half-year consolidated net profit reaching ₹27,254 million. The board approved unaudited financials on November 6, 2025. Strategic acquisitions completed include Amplitude Surgical (85.6% stake, €256.8 million) and Comfort Click Limited (₹239 million equivalent). Consolidated assets grew to ₹468,973 million from ₹372,017 million year-end. Exceptional items including goodwill impairment totaled ₹1,350 million.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this board meeting affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 6 November 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 6 November 2025

SBIN State Bank of India Offer Document SBIN State Bank of India Offer Document SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results UNIONBANK Union Bank of India Financial Results WIPRO Wipro Limited Corporate Action SBIN State Bank of India Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.